Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewRo 5-3335 is a core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC50 = 1.1 μM). Represses RUNX1/CBFβ-dependent transactivation in reporter assays and inhibits transcriptional regulation by RUNX1 and CBFβ. Reduces leukemia burden in a mouse model. Attenuates RUNX1-dependent hematopoiesis in zebrafish embryos. Also a Tat antagonist; inhibits HIV-1 replication in vitro.
Ro 5-3335 is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.
M. Wt | 259.69 |
Formula | C13H10ClN3O |
Storage | Store at +4°C |
Purity | ≥98% (HPLC) |
CAS Number | 30195-30-3 |
PubChem ID | 64983 |
InChI Key | XWNMORIHKRROGW-UHFFFAOYSA-N |
Smiles | O=C1CN=C(C3=CC=CN3)C2=C(C=CC(Cl)=C2)N1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 25.96 | 100 |
The following data is based on the product molecular weight 259.69. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 3.85 mL | 19.25 mL | 38.51 mL |
5 mM | 0.77 mL | 3.85 mL | 7.7 mL |
10 mM | 0.39 mL | 1.93 mL | 3.85 mL |
50 mM | 0.08 mL | 0.39 mL | 0.77 mL |
References are publications that support the biological activity of the product.
Cunningham et al (2012) Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBF beta interaction. Proc.Natl.Acad.Sci.USA 109 14592 PMID: 22912405
Cupelli et al (1995) The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter. J.Virol. 69 2640 PMID: 7884917
Okuda et al (2001) RUNX1/AML1: a central player in hematopoiesis. Int. J. Hematol. 74 252 PMID: 11721959
If you know of a relevant reference for Ro 5-3335, please let us know.
Keywords: Ro 5-3335, Ro 5-3335 supplier, Ro5-3335, CBF, core, binding, factor, Leukemia, inhibitors, inhibits, runt-related, transcription, 1, RUNX1, acute, myeloid, leukemia, protein, AML1, CBFβ, CBFα, hematopoiesis, HIV-1, replication, antiviral, CBFβ-Runx1, II, CBFbeta-Runx1, inhibitor, Other, Transcription, Factors, 4694, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for Ro 5-3335 include:
Luo et al (2016) Runt-related Transcription Factor 1 (RUNX1) Binds to p50 in Macrophages and Enhances TLR4-triggeredInflammation and Septic Shock. Journal of Biological Chemistry PMID: 27573239
Jean Y et al (2022) LY6D marks pre-existing resistant basosquamous tumor subpopulations. Nat Commun 13 7520 PMID: 36473848
Do you know of a great paper that uses Ro 5-3335 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review Ro 5-3335 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image